Chordate Medical Holding AB (ST:CMH) — Stock Price

Skr0.10 SEK
▼ -37.50% today

Chordate Medical Holding AB (ST:CMH) is currently trading at Skr0.10 SEK, down 37.50% today. Over the past 52 weeks, shares have ranged between Skr0.10 and Skr9.00. This page tracks Chordate Medical Holding AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see CMH company net worth.

Chordate Medical Holding AB (CMH) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Chordate Medical Holding AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Chordate Medical Holding AB Income Statement — Revenue, Profit & Earnings by Year

Chordate Medical Holding AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue Skr664.69K Skr976.28K Skr108.52K Skr882.05K Skr618.01K
Cost of Revenue Skr-1.32 Million Skr-332.90K Skr74.45K Skr-1.04 Million Skr-1.90 Million
Gross Profit Skr1.99 Million Skr1.31 Million Skr34.06K Skr1.93 Million Skr2.51 Million
Research & Development Skr1.22 Million Skr1.22 Million Skr1.22 Million Skr304.06K Skr1.20 Million
SG&A Skr19.83 Million Skr16.46 Million Skr13.69 Million
Total Operating Expenses Skr29.43 Million Skr30.88 Million Skr28.06 Million Skr23.67 Million Skr21.93 Million
Operating Income Skr-27.45 Million Skr-29.57 Million Skr-28.02 Million Skr-21.74 Million Skr-19.42 Million
EBITDA Skr-25.23 Million Skr-27.94 Million Skr-26.79 Million Skr-20.50 Million Skr-18.05 Million
EBIT Skr-27.45 Million Skr-29.18 Million Skr-28.02 Million Skr-21.74 Million Skr-19.42 Million
Interest Expense Skr5.53K Skr6.68K Skr81.15K Skr24.89K Skr338.27K
Income Before Tax Skr-27.25 Million Skr-29.19 Million Skr-27.94 Million Skr-21.77 Million Skr-19.76 Million
Income Tax Expense Skr-3.00 Skr-81.15K Skr24.89K Skr338.27K
Net Income Skr-27.25 Million Skr-29.19 Million Skr-27.94 Million Skr-21.77 Million Skr-19.76 Million

Chordate Medical Holding AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Chordate Medical Holding AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets Skr17.53 Million Skr21.96 Million Skr18.64 Million Skr44.06 Million Skr31.22 Million
Total Current Assets Skr7.67 Million Skr12.76 Million Skr8.15 Million Skr31.50 Million Skr18.42 Million
Cash & Equivalents
Short-term Investments Skr-1.00
Net Receivables Skr1.30 Million Skr1.67 Million Skr1.18 Million Skr1.05 Million Skr1.72 Million
Inventory Skr1.77 Million Skr1.77 Million Skr1.37 Million Skr1.17 Million Skr729.90K
Property, Plant & Equipment Skr675.45K Skr546.08K Skr806.20K
Goodwill Skr0.00 Skr1.00 Skr0.00 Skr0.00
Total Liabilities Skr8.34 Million Skr6.87 Million Skr7.57 Million Skr5.11 Million Skr5.58 Million
Total Current Liabilities Skr8.34 Million Skr6.87 Million Skr7.57 Million Skr5.11 Million Skr5.58 Million
Long-term Debt
Net Debt Skr-2.53 Million Skr-8.46 Million Skr-3.68 Million Skr-28.98 Million Skr-15.54 Million
Total Stockholder Equity Skr9.20 Million Skr15.09 Million Skr11.07 Million Skr38.95 Million Skr25.64 Million
Retained Earnings Skr-27.25 Million Skr-316.69 Million Skr-287.50 Million Skr-21.77 Million Skr-19.76 Million

Chordate Medical Holding AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Chordate Medical Holding AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow Skr-24.41 Million Skr-27.26 Million Skr-24.98 Million Skr-20.34 Million Skr-17.43 Million
Capital Expenditures Skr2.88 Million Skr1.15 Million Skr389.49K Skr1.30 Million Skr3.12 Million
Free Cash Flow Skr-27.29 Million Skr-28.41 Million Skr-25.37 Million Skr-21.64 Million Skr-20.55 Million
Investing Cash Flow Skr-2.88 Million Skr-1.16 Million Skr-389.49K Skr-1.30 Million Skr-3.12 Million
Financing Cash Flow Skr21.36 Million Skr33.20 Million Skr65.21K Skr35.08 Million Skr32.54 Million
Dividends Paid
Stock-Based Compensation
Depreciation Skr1.00 Million Skr1.24 Million Skr2.45 Million Skr1.54 Million Skr2.57 Million
Change in Cash Skr-5.93 Million Skr4.78 Million Skr-25.30 Million Skr13.44 Million Skr11.98 Million

Chordate Medical Holding AB Earnings History — EPS Actual vs. Analyst Estimates

Track Chordate Medical Holding AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Aug 29, 2025 -1.92
May 23, 2025 -2.84
Mar 28, 2025 -5.84
Nov 25, 2024 -4.12
Aug 30, 2024 -5.11
May 10, 2024 -0.02
Jan 26, 2024 -0.03
Nov 01, 2023 -5.73